Detection rate and variables associated with incidental prostate cancer by holmium laser enucleation of the prostate

Int J Urol. 2022 Aug;29(8):860-865. doi: 10.1111/iju.14917. Epub 2022 May 18.

Abstract

Objectives: Holmium laser enucleation of the prostate is well-established and effective for bladder outlet obstruction due to benign prostatic hyperplasia. The objective of this study was to examine the detection rate of incidental prostate cancer by holmium laser enucleation of the prostate and variables associated with them.

Methods: A total of 612 patients were enrolled. We retrospectively examined the detection rate of incidental prostate cancer and perioperative variables associated with them.

Results: Forty-nine of 612 patients were diagnosed with incidental prostate cancer. Univariate logistic regression analysis showed that higher prostate-specific antigen density (odds ratio 3.34, 95% confidence interval 1.02-10.94, P = 0.05), higher prostate-specific antigen density of the transition zone (odds ratio 2.28, 95% confidence interval 1.02-5.09, P = 0.04), and findings of the prostate cancer on magnetic resonance imaging (peripheral zone: odds ratio 4.71, 95% confidence interval 1.70-13.1, P = 0.003; transition zone: odds ratio 3.46, 95% confidence interval 1.74-6.86, P < 0.001; peripheral and transition zones: odds ratio 6.00, 95% confidence interval 1.51-23.8, P = 0.01) were significantly associated with incidental prostate cancer. Multivariate logistic regression analysis showed that findings of the prostate cancer on magnetic resonance imaging (peripheral zone: odds ratio 4.36, 95% confidence interval 1.49-12.8, P = 0.001; transition zone: odds ratio 3.54, 95% confidence interval 1.75-7.16, P < 0.001; peripheral and transition zones: odds ratio 6.14, 95% confidence interval 1.53-24.5, P = 0.01) was an independent risk factor for incidental prostate cancer.

Conclusion: The detection rate of incidental prostate cancer was 8.0%, and findings of the prostate cancer on magnetic resonance imaging were an independent predictive factor for incidental prostate cancer.

Keywords: prostate-specific antigen; prostatic hyperplasia; prostatic neoplasms; urologic surgery procedures; urology.

MeSH terms

  • Humans
  • Laser Therapy* / methods
  • Lasers, Solid-State* / therapeutic use
  • Male
  • Prostate / diagnostic imaging
  • Prostate / pathology
  • Prostate / surgery
  • Prostate-Specific Antigen
  • Prostatic Hyperplasia* / complications
  • Prostatic Hyperplasia* / diagnostic imaging
  • Prostatic Hyperplasia* / surgery
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / epidemiology
  • Prostatic Neoplasms* / surgery
  • Retrospective Studies
  • Transurethral Resection of Prostate* / methods
  • Treatment Outcome

Substances

  • Prostate-Specific Antigen